ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 174.02%
This Quarter Est. Return
1 Year Est. Return
+174.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$616M
AUM Growth
+$96.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
239
New
Increased
Reduced
Closed

Top Buys

1
+$52.1M
2
+$20.5M
3
+$14M
4
CTMX icon
CytomX Therapeutics
CTMX
+$6.89M
5
ABVX
Abivax
ABVX
+$6.59M

Top Sells

1
+$17.4M
2
+$8.63M
3
+$6.94M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.34M
5
AVR
Anteris Technologies
AVR
+$4.35M

Sector Composition

1 Healthcare 83.61%
2 Financials 2.95%
3 Consumer Discretionary 0%
4 Industrials 0%
5 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHVS icon
101
Pharvaris
PHVS
$1.53B
$601K 0.09%
+34,124
LXEO icon
102
Lexeo Therapeutics
LXEO
$660M
$583K 0.09%
145,109
-25,339
KYMR icon
103
Kymera Therapeutics
KYMR
$4.67B
$583K 0.09%
13,366
+3,366
OABI icon
104
OmniAb
OABI
$225M
$567K 0.09%
326,108
+200,000
MRK icon
105
Merck
MRK
$231B
$557K 0.09%
+7,040
LUNG icon
106
Pulmonx
LUNG
$61.5M
$530K 0.08%
+204,497
GRCE
107
Grace Therapeutics
GRCE
$46.4M
$525K 0.08%
176,627
-166,885
EWTX icon
108
Edgewise Therapeutics
EWTX
$2.41B
$524K 0.08%
40,000
+20,000
AVTX icon
109
Avalo Therapeutics
AVTX
$274M
$523K 0.08%
104,730
+94,730
SYRE icon
110
Spyre Therapeutics
SYRE
$1.82B
$510K 0.08%
34,051
+19,018
USFR icon
111
WisdomTree Floating Rate Treasury Fund
USFR
$18.3B
$503K 0.08%
10,000
DNLI icon
112
Denali Therapeutics
DNLI
$2.56B
$500K 0.08%
35,716
+21,843
SNY icon
113
Sanofi
SNY
$127B
$483K 0.07%
+10,000
KPRX icon
114
Kiora Pharmaceuticals
KPRX
$7.94M
$481K 0.07%
167,111
-27,554
BHVN icon
115
Biohaven
BHVN
$879M
$456K 0.07%
32,341
+9,700
NGNE icon
116
Neurogene
NGNE
$325M
$443K 0.07%
29,625
+1,700
NETD icon
117
Nabors Energy Transition Corp II
NETD
$242M
$443K 0.07%
39,900
NTRA icon
118
Natera
NTRA
$28.2B
$422K 0.06%
2,500
-1,750
SPRO icon
119
Spero Therapeutics
SPRO
$136M
$417K 0.06%
143,917
-657,360
NKTR icon
120
Nektar Therapeutics
NKTR
$1.15B
$408K 0.06%
15,796
+11,279
LLY icon
121
Eli Lilly
LLY
$918B
$390K 0.06%
500
-100
TARA icon
122
Protara Therapeutics
TARA
$213M
$372K 0.06%
122,690
FULC icon
123
Fulcrum Therapeutics
FULC
$468M
$367K 0.06%
53,349
-437,183
PYPD icon
124
PolyPid
PYPD
$57.1M
$367K 0.06%
103,950
+23,870
VTYX icon
125
Ventyx Biosciences
VTYX
$660M
$361K 0.06%
168,600
-113,000
3 4
5
6 7